US Point of Care Diagnostics Market

The report "US Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031", is estimated to grow from USD 6.8 billion in 2026 to USD 10.6 billion by 2031, at a CAGR of 9.2% during the period.

Browse 130 market data Tables and 54 Figures spread through 200 Pages and in-depth TOC on "US Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/united-states-point-of-care-diagnostics-market-4836793.html

The US point of care diagnostics market is experiencing significant growth. One of the main factors driving this market is the increasing prevalence of chronic diseases, particularly diabetes. As more people are diagnosed with diabetes and other conditions, the demand for point-of-care diagnostic solutions has risen to ensure accurate and timely diagnosis.

In addition to the rise in chronic diseases, the growing popularity of CLIA-waived point-of-care tests has encouraged healthcare providers to adopt these tests more widely. Furthermore, increased government spending on screening programs and a shift toward decentralized medical models have improved access to various tests, enhancing the need for point-of-care diagnostics.

These initiatives aim to facilitate timely disease diagnosis and offer cost-effective healthcare services while prioritizing population health, ultimately leading to higher demand for point-of-care diagnostics.

“By purchase mode, prescription-based testing products registered the largest market share in 2025.”

The US point of care diagnostics market is divided into two main segments: over-the-counter testing products and prescription-based testing products. Prescription-based tests are commonly used in clinics across the US and play a vital role in diagnosing and treating various diseases. The increasing prevalence of conditions such as diabetes, cardiovascular disease (CVD), and infectious diseases has further fueled the demand for prescription-based point-of-care (POC) tests, as they provide accurate results that aid in treatment decisions. Additionally, strict adherence to established guidelines and standards ensures high-quality results, making prescription-based tests a widely accepted option in the US point of care diagnostics market.

“By end user, the home care settings & self-testing segment accounted for the largest market share in 2025.”

The market is divided by end users into several categories, including clinical laboratories, ambulatory care facilities, physician offices, hospitals, critical care centers, urgent care centers, home care settings & self-testing, and other end users. The increasing demand for convenience and patient comfort has led to a rise in home-based testing solutions. These solutions allow patients to monitor their health conditions from the comfort of their homes, eliminating the need for frequent visits to healthcare facilities. The ability to receive rapid results is particularly beneficial for chronic health conditions, such as diabetes, which has further increased the demand for self-testing options. Advancements in technology have made home-based tests more accurate, user-friendly, and cost-effective, enabling patients to conduct these tests with minimal training. As the incidence of chronic health conditions rises and there is greater emphasis on preventive care and self-management, the home care settings & self-testing segment remains the dominant market in the US point of care diagnostics sector.

The major players operating in this market are Siemens (Germany), Abbott Diagnostics (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Quidel Corporation (US), Thermo Fisher (US), Becton, Dickinson and Company (US), BIOSYNEX (France), bioMérieux (France), and EKF Diagnostics (UK).

Don’t miss out on business opportunities in US Point of Care Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/